Optimal treatment of laryngopharyngeal reflux disease

被引:68
作者
Martinucci, Irene [1 ]
de Bortoli, Nicola [1 ,2 ]
Savarino, Edoardo [3 ]
Nacci, Andrea [4 ]
Romeo, Salvatore Osvaldo [4 ]
Bellini, Massimo [1 ]
Savarino, Vincenzo [5 ]
Fattori, Bruno [4 ]
Marchi, Santino [1 ]
机构
[1] Univ Pisa, Gastroenterol Unit, Via Paradisa 2, I-56124 Pisa, PI, Italy
[2] Cisanello Hosp, I-56124 Pisa, PI, Italy
[3] Univ Padua, Div Gastroenterol, Padua, Italy
[4] Univ Pisa, Ear Nose & Throat Audiol Phoniatr Unit, Pisa, Italy
[5] Univ Genoa, Dept Internal Med DIMI, Div Gastroenterol, Genoa, Italy
关键词
gastroesophageal reflux disease; laryngopharyngeal reflux; proton pump inhibitor; treatment;
D O I
10.1177/2040622313503485
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Laryngopharyngeal reflux is defined as the reflux of gastric content into larynx and pharynx. A large number of data suggest the growing prevalence of laryngopharyngeal symptoms in patients with gastroesophageal reflux disease. However, laryngopharyngeal reflux is a multifactorial syndrome and gastroesophageal reflux disease is not the only cause involved in its pathogenesis. Current critical issues in diagnosing laryngopharyngeal reflux are many nonspecific laryngeal symptoms and signs, and poor sensitivity and specificity of all currently available diagnostic tests. Although it is a pragmatic clinical strategy to start with empiric trials of proton pump inhibitors, many patients with suspected laryngopharyngeal reflux have persistent symptoms despite maximal acid suppression therapy. Overall, there are scant conflicting results to assess the effect of reflux treatments (including dietary and lifestyle modification, medical treatment, antireflux surgery) on laryngopharyngeal reflux. The present review is aimed at critically discussing the current treatment options in patients with laryngopharyngeal reflux, and provides a perspective on the development of new therapies.
引用
收藏
页码:287 / 301
页数:15
相关论文
共 145 条
[1]   A Review of Clinical Practice Guidelines for Reflux Disease: Toward Creating a Clinical Protocol for the Otolaryngologist [J].
Altman, Kenneth W. ;
Prufer, Neil ;
Vaezi, Michael F. .
LARYNGOSCOPE, 2011, 121 (04) :717-723
[2]   Reductions in Medications with Substantial Weight Loss with Behavioral Intervention [J].
Anderson, James W. ;
Jhaveri, Manan A. .
CURRENT CLINICAL PHARMACOLOGY, 2010, 5 (04) :232-238
[3]  
Bardhan Karna Dev, 2012, Int J Otolaryngol, V2012, P646901, DOI 10.1155/2012/646901
[4]  
BOUGH ID, 1995, VOICE, V9, P205
[5]   The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease [J].
Branski, RC ;
Bhattacharyya, N ;
Shapiro, J .
LARYNGOSCOPE, 2002, 112 (06) :1019-1024
[6]   EFFECT OF DIFFERENT COFFEES ON ESOPHAGEAL ACID CONTACT TIME AND SYMPTOMS IN COFFEE-SENSITIVE SUBJECTS [J].
BRAZER, SR ;
ONKEN, JE ;
DALTON, CB ;
SMITH, JW ;
SCHIFFMAN, SS .
PHYSIOLOGY & BEHAVIOR, 1995, 57 (03) :563-567
[7]   Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study [J].
Broekaert, D ;
Fischler, B ;
Sifrim, D ;
Janssens, J ;
Tack, J .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) :365-370
[8]   pH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures [J].
Carroll, Thomas L. ;
Fedore, Lauren W. ;
Aldahlawi, Moataz M. .
LARYNGOSCOPE, 2012, 122 (11) :2473-2481
[9]   Laparoscopic nissen fundoplication effectively relieves symptoms in patients with laryngopharyngeal reflux [J].
Catania, Robert A. ;
Kavic, Stephen M. ;
Roth, J. Scott ;
Lee, Tommy H. ;
Meyer, Tanya ;
Fantry, George T. ;
Castellanos, Paul F. ;
Park, Adrian .
JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (12) :1579-1587
[10]   Results of laparoscopic fundoplication where atypical symptoms coexist with oesophageal reflux [J].
Chen, RYM ;
Thomas, RJS .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 2000, 70 (12) :840-842